What are the microscopic findings of coronary atherosclerosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Microscopic Findings of Coronary Atherosclerosis

Coronary atherosclerosis is characterized microscopically by the accumulation of lipid-laden macrophages (foam cells) in the arterial intima, forming the earliest lesion known as a fatty streak, which progresses to complex plaques containing a lipid-rich necrotic core covered by a fibrous cap composed of smooth muscle cells and extracellular matrix.

Early Lesions: Fatty Streaks

  • The earliest pathological abnormality is the fatty streak, consisting of lipid-filled macrophages (foam cells) accumulating within the arterial intima 1
  • Circulating monocytes migrate into the subintimal space, transform into macrophages, and take up oxidized LDL particles to form foam cells 2
  • LDL particles enter the arterial intima through passive molecular sieving and become trapped as they cannot penetrate the elastic laminas of the media 2
  • Oxidized LDL must undergo modification before macrophages can take it up to form foam cells 2

Progressive Plaque Development

  • With increasing age and continued lipid accumulation, macrophages and smooth muscle cells proliferate and migrate into the intima and media to form fibrous plaque lesions 1
  • The mature atherosclerotic plaque consists of a large necrotic core formed by macrophage foam cells, overlaid by a fibrous cap composed of smooth muscle cells and extracellular matrix 3
  • Macrophages are recognized as the hallmark cells of atherosclerotic plaques and are key players in the atherosclerotic process 1, 2

Vulnerable Plaque Characteristics

  • Unstable or vulnerable plaques contain a soft, lipid-rich necrotic core covered by a thin, inflamed fibrous cap (thin-capped fibroatheroma) 1
  • The thin fibrous cap measures approximately 70 µm in thickness 1
  • These vulnerable plaques demonstrate intense accumulation of inflammatory cells, particularly macrophages, within the fibrous cap 1
  • A scarce presence of smooth muscle cells characterizes the thin fibrous cap of vulnerable plaques 4
  • Activated macrophages secrete metalloproteinases and other connective tissue enzymes that break down collagen, weakening the plaque cap and making it prone to rupture 2

Advanced and Complicated Lesions

  • Advanced fibrous plaques are vulnerable to rupture, initiating a cascade of events leading to thrombus formation 1
  • Plaque rupture or fissuring with subsequent thrombosis is what makes coronary atherosclerosis dangerous, potentially causing unstable angina, myocardial infarction, and sudden death 5
  • Complications can occur when vascularization of the plaque leads to hemorrhage and swelling within the plaque, causing occlusion of the arterial lumen 1
  • The risk of plaque disruption depends more on plaque composition (type) than on plaque size or stenosis severity 5

Cellular and Molecular Components

  • Foam cells form when macrophages become filled with indigestible cholesterol droplets after taking up oxidized LDL 2
  • Macrophages and foam cells in atherosclerotic plaques express lipoprotein lipase, which may stimulate foam cell formation from triglyceride-rich lipoproteins 2
  • The atherosclerotic process involves an imbalanced lipid metabolism and a maladaptive immune response entailing chronic inflammation of the arterial wall 6

Artery-Specific Patterns

  • Coronary atherosclerosis shows distinct patterns compared to other arteries, with lipid core plaques being more prevalent in individuals who die from coronary causes 7
  • The left anterior descending coronary artery demonstrates the highest prevalence of atherosclerotic plaques 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.